A systematic review and meta-analysis of neuromodulation therapies for substance use disorders.

Autor: Mehta DD; Addictions Division, CAMH, Toronto, ON, Canada. dhvani.mehta@mail.utoronto.ca.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. dhvani.mehta@mail.utoronto.ca., Praecht A; Addictions Division, CAMH, Toronto, ON, Canada.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Ward HB; Department of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN, USA., Sanches M; Addictions Division, CAMH, Toronto, ON, Canada., Sorkhou M; Addictions Division, CAMH, Toronto, ON, Canada.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Tang VM; Addictions Division, CAMH, Toronto, ON, Canada.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Steele VR; Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA., Hanlon CA; Brainsway, Inc., Winston-Salem, NC, USA., George TP; Addictions Division, CAMH, Toronto, ON, Canada. tony.george@camh.ca.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. tony.george@camh.ca.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Mar; Vol. 49 (4), pp. 649-680. Date of Electronic Publication: 2023 Dec 12.

Reporting checklists in neuroimaging: promoting transparency, replicability, and reproducibility.

Autor: Ekhtiari H; Department of Psychiatry, University of Minnesota, Minneapolis, MN, USA. ekhti001@umn.edu.; Laureate Institute for Brain Research, Tulsa, OK, USA. ekhti001@umn.edu., Zare-Bidoky M; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Sangchooli A; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, VIC, Australia., Valyan A; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Abi-Dargham A; Department of Psychiatry and Behavioral Health, Stony Brook University Renaissance School of Medicine, Stony Brook, NY, USA.; Department of Psychiatry, Columbia University Vagelos School of Medicine and New York State Psychiatric Institute, New York, NY, USA., Cannon DM; Clinical Neuroimaging Laboratory, Center for Neuroimaging, Cognition & Genomics, College of Medicine, Nursing & Health Sciences, University of Galway, Galway, Ireland., Carter CS; Department of Psychiatry and Human Behavior, University of California at Irvine, Irvine, CA, USA., Garavan H; Departments of Psychiatry and Psychology, University of Vermont, Burlington, VT, USA., George TP; Institute for Mental Health Policy and Research at CAMH, Toronto, ON, Canada.; Department of Psychiatry, Institute of Medical Sciences, University of Toronto, Toronto, ON, Canada., Ghobadi-Azbari P; Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran., Juchem C; Department of Biomedical Engineering, Columbia University Fu Foundation, School of Engineering and Applied Science, New York, NY, USA.; Department of Radiology, Columbia University College of Physicians and Surgeons, New York, NY, USA., Krystal JH; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.; U.S. Department of Veterans Affairs National Center for Posttraumatic Stress Disorder, Clinical Neurosciences Division, VA Connecticut Healthcare System, West Haven, CT, USA., Nichols TE; Nuffield Department of Population Health, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, University of Oxford, Oxford, UK., Öngür D; McLean Hospital, Belmont, MA, USA.; Department of Psychiatry, Harvard Medical School, Boston, MA, USA., Pernet CR; Neurobiology Research Unit, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Poldrack RA; Department of Psychology, Stanford University, Stanford, CA, USA., Thompson PM; Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA., Paulus MP; Laureate Institute for Brain Research, Tulsa, OK, USA.

Publikováno v: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2024 Nov; Vol. 50 (1), pp. 67-84. Date of Electronic Publication: 2024 Sep 06.

Corrigendum to "Separate and combined effects of alcohol and cannabis on mood, subjective experience, cognition and psychomotor performance: A randomized trial" [Progress in Neuropsychopharmacology & Biological Psychiatry 118 (2022) 110570].

Autor: Wickens CM; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada. Electronic address: Christine.Wickens@camh.ca., Wright M; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada., Mann RE; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Brands B; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Controlled Substances and Cannabis Directorate, Health Canada, Ottawa, Ontario, Canada., Di Ciano P; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada., Stoduto G; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Fares A; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada., Matheson J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada., George TP; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada., Rehm J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation; Klinische Psychologie & Psychotherapie, Technische Universität Dresden, Dresden, Germany., Shuper PA; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Sproule B; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada; Pharmacy Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada., Samohkvalov A; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Addictions Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada., Huestis MA; Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, PA, USA., Le Foll B; Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ontario, Canada; Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Klinische Psychologie & Psychotherapie, Technische Universität Dresden, Dresden, Germany; Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.

Publikováno v: Progress in neuro-psychopharmacology & biological psychiatry [Prog Neuropsychopharmacol Biol Psychiatry] 2024 Aug 30; Vol. 134, pp. 111074. Date of Electronic Publication: 2024 Jun 26.

Feasibility and effectiveness of extended-release buprenorphine (XR-BUP) among correctional populations: a systematic review.

Autor: Russell C; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Ontario Node, Canadian Research Initiative in Substance Misuse (CRISM), Toronto, ON, Canada., George TP; Institute of Medical Science (IMS), University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Chopra N; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada., Le Foll B; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Ontario Node, Canadian Research Initiative in Substance Misuse (CRISM), Toronto, ON, Canada.; Institute of Medical Science (IMS), University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Addictions Division, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Translational Addiction Research Laboratory, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, ON, Canada., Matheson FI; Institute of Medical Science (IMS), University of Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; MAP Centre for Urban Health Solutions, St. Michael's Hospital, a site of Unity Health Toronto, Toronto, ON, Canada.; Centre for Criminology & Sociolegal Studies, University of Toronto, Toronto, ON, Canada., Rehm J; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Ontario Node, Canadian Research Initiative in Substance Misuse (CRISM), Toronto, ON, Canada.; Institute of Medical Science (IMS), University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Institut für Klinische Psychologie und Psychotherapie, Technische Universität Dresden, Dresden, Germany.; Center for Interdisciplinary Addiction Research (ZIS), Department of Psychiatry and Psychotherapy, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany., Lange S; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.; Institute of Medical Science (IMS), University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

Publikováno v: The American journal of drug and alcohol abuse [Am J Drug Alcohol Abuse] 2024 Jun 28, pp. 1-20. Date of Electronic Publication: 2024 Jun 28.

Training in Substance Use Disorders, Part 2: Updated Curriculum Guidelines.

Autor: Crockford D; Clinical Professor, Department of Psychiatry, University of Calgary, Cumming School of Medicine, Calgary, AB, Canada; Hotchkiss Brain Institute & Mathison Centre for Mental Health Research & Education, University of Calgary, Calgary, AB, Canada., Bahji A; Clinical Assistant Professor, Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada., Schutz C; Professor, Institute of Mental Health, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; Research Lead Adult Mental Health and Substance Use, Provincial Health Service Authority, BC, Canada., Brasch J; Associate Professor, Department of Psychiatry & Behavioural Neurosciences, Michael G DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Lead, Addiction Psychiatry, St. Joseph's Healthcare, Hamilton, ON, Canada; Past-President, Canadian Society of Addiction Medicine, Vancouver, BC, Canada., Buckley L; Associate Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Centre for Addiction and Mental Health, Toronto, ON, Canada., Danilewitz M; Assistant Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Associate Medical Director, General Psychiatry, Ontario Shores Centre for Mental Health Sciences, Whitby, ON, Canada., Dubreucq S; Psychiatrist, Department of Addiction Medicine, CHUM, Montreal, QC, Canada; Assistant Professor, Department of Psychiatry, Université de Montréal, Montréal, QC, Canada., Mak M; Assistant Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Adjunct Assistant Professor, Department of Medicine, McMaster University, Hamilton, ON, Canada; Adjunct Research Professor, Department of Psychiatry, Western University, London, ON, Canada., George TP; Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Publikováno v: Canadian journal of psychiatry. Revue canadienne de psychiatrie [Can J Psychiatry] 2024 Jun; Vol. 69 (6), pp. 457-478. Date of Electronic Publication: 2024 Mar 27.